Patents by Inventor Dennis R. Stewart

Dennis R. Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160287672
    Abstract: The present disclosure relates to methods for treating human subjects afflicted with chronic heart failure. The methods described herein employ administration of relaxin.
    Type: Application
    Filed: April 25, 2016
    Publication date: October 6, 2016
    Inventors: Elaine Unemori, Sam Teichman, Thomas Dschietzig, Dennis R. Stewart, Martha Jo Whitehouse
  • Publication number: 20140005112
    Abstract: The present disclosure relates to methods for treating human subjects afflicted with chronic heart failure. The methods described herein employ administration of relaxin.
    Type: Application
    Filed: July 11, 2013
    Publication date: January 2, 2014
    Inventors: Elaine Unemori, Sam Teichman, Thomas Dschietzig, Dennis R. Stewart, Martha Jo Whitehouse
  • Patent number: 8415301
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: April 9, 2013
    Assignee: Corthera, Inc.
    Inventors: Elaine Unemori, Sam L Teichman, Gad Cotter, Dennis R Stewart, Martha J Whitehouse
  • Patent number: 8372809
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: February 12, 2013
    Assignee: Corthera, Inc.
    Inventors: Elaine Unemori, Sam L Teichman, Gad Cotter, Dennis R Stewart, Martha J Whitehouse
  • Publication number: 20120040902
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: September 23, 2011
    Publication date: February 16, 2012
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis R. Stewart, Martha Jo Whitehouse
  • Publication number: 20120040903
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: May 15, 2009
    Publication date: February 16, 2012
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis R. Stewart, Martha J. Whitehouse
  • Patent number: 8053411
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: November 8, 2011
    Assignee: Corthera, Inc.
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis R. Stewart, Martha Jo Whitehouse
  • Publication number: 20110166070
    Abstract: The disclosure pertains to methods of decreasing the risk of premature birth and miscarriage in human females. Particularly, the disclosure provides methods of reducing cervical dialation and preterm delivery by administration of relaxin.
    Type: Application
    Filed: May 15, 2009
    Publication date: July 7, 2011
    Inventor: Dennis R. Stewart
  • Publication number: 20110144019
    Abstract: The present disclosure relates to methods for treating human subjects afflicted with chronic heart failure. The methods described herein employ administration of relaxin.
    Type: Application
    Filed: May 15, 2009
    Publication date: June 16, 2011
    Inventors: Elaine Unemori, Sam L. Teichman, Thomas Dschietzig, Dennis R. Stewart, Martha J. Whitehouse
  • Publication number: 20110092439
    Abstract: The present disclosure relates to methods of administering relaxin to promote wound healing and reduce scar formation. The disclosure further contemplates the use of relaxin in reconstructive and plastic surgery.
    Type: Application
    Filed: May 13, 2009
    Publication date: April 21, 2011
    Inventor: Dennis R. Stewart
  • Publication number: 20100048475
    Abstract: The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutically effective amount of relaxin.
    Type: Application
    Filed: May 15, 2009
    Publication date: February 25, 2010
    Applicant: Corthera, Inc.
    Inventors: Elaine Unemori, Sam L. Teichman, Gad Cotter, Dennis R. Stewart, Martha Jo Whitehouse
  • Publication number: 20100041603
    Abstract: The present disclosure relates to methods of administering relaxin to promote wound healing and reduce scar formation. The disclosure further contemplates the use of relaxin in reconstructive and plastic surgery.
    Type: Application
    Filed: May 13, 2009
    Publication date: February 18, 2010
    Applicant: Corthera, Inc.
    Inventor: Dennis R. Stewart
  • Patent number: 6984128
    Abstract: Orthodontic methods comprise applying force to reposition teeth and administering a tissue remodeling and/or an angiogenic substance(s) to the periodontal tissue surrounding the teeth to be moved. The substance(s) may be delivered before, during, or after the teeth are moved, and the substance(s) may be selectively applied only to those teeth undergoing movement at any particular time. The substance(s) may be applied from the dental repositioning appliance or may be applied separately, either topically or by injection.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: January 10, 2006
    Assignee: BAS Medical, Inc.
    Inventors: Peter M. Breining, Dennis R. Stewart
  • Publication number: 20040115587
    Abstract: Orthodontic methods comprise applying force to reposition teeth and administering a tissue remodeling and/or an angiogenic substance(s) to the periodontal tissue surrounding the teeth to be moved. The substance(s) may be delivered before, during, or after the teeth are moved, and the substance(s) may be selectively applied only to those teeth undergoing movement at any particular time. The substance(s) may be applied from the dental repositioning appliance or may be applied separately, either topically or by injection.
    Type: Application
    Filed: October 27, 2003
    Publication date: June 17, 2004
    Applicant: BAS Medical, Inc.
    Inventors: Peter M. Breining, Dennis R. Stewart
  • Patent number: 6660531
    Abstract: A method of determining the probability of an in vitro fertilization (IVF) or embryo transfer (ET) method being successful is disclosed. Relaxin can be measured directly in the serum or indirectly by culturing granulosa lutein cells extracted from the patient as part of an IVF/ET procedure. A method of enhancing the rate of a successful pregnancy resulting from an IVF/ET procedure is also disclosed whereby relaxin is administered and/or endogenous relaxin levels are enhanced by varying convention IVF/ET procedures.
    Type: Grant
    Filed: June 22, 1998
    Date of Patent: December 9, 2003
    Assignee: The Regents of the University of California
    Inventors: Dennis R. Stewart, Catherine A. VandeVoort
  • Publication number: 20010053553
    Abstract: A method of determining the probability of an in vitro fertilization (IVF) or embryo transfer (ET) method being successful is disclosed. Relaxin can be measured directly in the serum or indirectly by culturing granulosa lutein cells extracted from the patient as part of an IVF/ET procedure. A method of enhancing the rate of a successful pregnancy resulting from an IVF/ET procedure is also disclosed whereby relaxin is administered and/or endogenous relaxin levels are enhanced by varying convention IVF/ET procedures.
    Type: Application
    Filed: June 22, 1998
    Publication date: December 20, 2001
    Inventor: DENNIS R. STEWART
  • Patent number: 5994148
    Abstract: A method of determining the probability of an in vitro fertilization (IVF) or embryo transfer (ET) method being successful is disclosed. Relaxin can be measured directly in the serum or indirectly by culturing granulosa lutein cells extracted from the patient as part of an IVF/ET procedure. A method of enhancing the rate of a successful pregnancy resulting from an IVF/ET procedure is also disclosed whereby relaxin is administered.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: November 30, 1999
    Assignee: The Regents of University of California
    Inventors: Dennis R. Stewart, Catherine A. Vandervoort